Click Here!Click Here!
Home / Health / AstraZeneca Gets FDA Approval for Ovarian Cancer Drug
AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

AstraZeneca Gets FDA Approval for Ovarian Cancer Drug

In what regulators called a latest allege in a growth of personalized medicine, a U.S. Food and Drug Administration on Friday authorized a initial drug to provide cases of ovarian cancer related to specific genetic mutations.

The drug, done by AstraZeneca PLC, was authorized for women with poor genes, famous as BRCA1 and BRCA2, who have modernized ovarian cancer. The mutations, initial detected in a mid-1990s, are related to as many as 15% of all ovarian cancers and adult to 10% of all breast cancers. Last year,…

About admin

Scroll To Top